Latest Asx News

Aguia Resources Limited has reduced its Share Purchase Plan price to 3.6 cents and extended the closing date, while reporting promising initial drill results at its Santa Barbara gold project and securing a $4 million loan to kickstart phosphate production in Brazil.

Blaze Minerals has inked a binding deal to acquire a major interest in the Loulombo Base Metals Project in the Republic of Congo, backed by a $2.52 million capital raise to fund exploration and development.

Lumos Diagnostics has enrolled 500 patients in its FebriDx CLIA waiver clinical study, unlocking a significant milestone payment from BARDA and moving closer to FDA approval that could open a US$1 billion market.

Emyria has landed a multi-year funding deal with Medibank to support its Empax PTSD program at Perth Clinic, marking a first for private insurer-backed psychotherapy in Australia. The company also announces a $4 million capital raise to fuel national expansion.

Staude Capital Global Value Fund Limited (GVF) launches a Share Purchase Plan offering existing shareholders a chance to invest up to $30,000 at a price near its net asset value, following nearly five years without a capital raise.

Viva Leisure has launched a refreshed corporate brand and published 'The Viva Story,' outlining its transformation into a global, technology-driven fitness ecosystem.

Askari Metals is advancing its African exploration strategy with detailed field campaigns targeting tin, tantalum, and gold mineralisation in Namibia and Ethiopia, while evaluating strategic acquisitions to bolster its portfolio.

X2M Connect Limited has secured $1.95 million through a share placement and convertible note conversion, aiming to strengthen its balance sheet and accelerate growth in AI and IoT sectors.

Firetail Resources has identified an 800-metre strike of high-grade copper-only mineralisation at the Earl’s Target within its Skyline Copper Project in Newfoundland, bolstering the case for Cyprus-style VMS deposits in the region.

Ionic Rare Earths is broadening its Viridion Joint Venture to include a US-based rare earth refinery, aiming to strengthen a secure supply chain for critical magnet and heavy rare earth oxides outside China.

Waratah Minerals has confirmed significant extensions to its Spur Gold Corridor in NSW, revealing high-grade gold intercepts and promising porphyry copper-gold mineralisation. The expanded drilling program aims to unlock further potential in this emerging gold discovery.

Mayne Pharma shareholders have overwhelmingly approved the scheme of arrangement for Cosette Pharmaceuticals to acquire the company at $7.40 per share, despite ongoing legal challenges and regulatory approvals still pending.